基本信息
浏览量:674
职业迁徙
个人简介
My research program is targeted to define mechanisms and approaches to induce a state of long-term tolerance in transplant patients. Our work grew out of the basic science in which we identified the unique Treg immunosuppressive molecule fibrinogen like protein 2 (FGL2). Through industry and academic collaborations, we have shown the relevance of fgl2 to the pathogenesis of viral disease, cancer and transplantation. We have now entered into partnership agreements to establish ELISA assays for both human and fgl2 which can be used to detect fgl2 in the plasma/serum of cancer patients and transplant patients. Industry partnerships are now examining the potential utility of an antibody to fgl2 as a cancer checkpoint inhibitor.
研究兴趣
论文共 380 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Scientific Reportsno. 1 (2024): 787-787
Angie K. Puerto Nino,Fabricio Batistella Zasso, Atina Boonchit, Sabrin Salim,Raza Mirza,Joseph Ferenbok,Istvan Mucsi,Heather Boon,Gary Levy
PROGRESS IN TRANSPLANTATIONno. 4 (2023): 328-334
Hassan Sadozai,Vanessa Rojas-Luengas,Kaveh Farrokhi,Sajad Moshkelgosha, Qinli Guo, Wei He,Angela Li,Jianhua Zhang,Conan Chua, Dario Ferri, Muhtashim Mian,Oyedele Adeyi,
Clinical and experimental immunologyno. 1 (2023): 138-154
Senthilkumar Preethy,Naoki Yamamoto, Kottoorathu Mammen Cherian, Rajasekaran Premsekar,Gary A Levy,Rajappa Senthilkumar,Samuel JK Abraham
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Redox biology (2022): 102508-102508
Journal of Clinical and Experimental Hepatologyno. 6 (2022): 1428-1437
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn